Androgen receptor-mTOR crosstalk is regulated by testosterone availability: implication for prostate cancer cell survival.
about
Emerging critical role of molecular testing in diagnostic genitourinary pathologyMetabolomic profiling reveals a role for androgen in activating amino acid metabolism and methylation in prostate cancer cellsConcurrent HDAC and mTORC1 inhibition attenuate androgen receptor and hypoxia signaling associated with alterations in microRNA expressionRegulation of the pentose phosphate pathway by an androgen receptor-mTOR-mediated mechanism and its role in prostate cancer cell growth.Prenatal testosterone-induced fetal growth restriction is associated with down-regulation of rat placental amino acid transport.Remarkable inhibition of mTOR signaling by the combination of rapamycin and 1,4-phenylenebis(methylene)selenocyanate in human prostate cancer cells.Cotargeting Androgen Receptor Splice Variants and mTOR Signaling Pathway for the Treatment of Castration-Resistant Prostate CancerThe androgen receptor as an emerging target in hepatocellular carcinomaDevelopmental Programming: Prenatal Testosterone Excess and Insulin Signaling Disruptions in Female Sheep.The effect of androgen receptor expression on clinical characterization of metastatic breast cancerA novel androgen-regulated isoform of the TSC2 tumour suppressor gene increases cell proliferation.Metabolomic profiling identifies biochemical pathways associated with castration-resistant prostate cancer.Antiandrogens act as selective androgen receptor modulators at the proteome level in prostate cancer cells.Resistance to the mTOR-inhibitor RAD001 elevates integrin α2- and β1-triggered motility, migration and invasion of prostate cancer cellsDual targeting of androgen receptor and mTORC1 by salinomycin in prostate cancer.The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer.Transcriptional Repression and Protein Degradation of the Ca2+-Activated K+ Channel KCa1.1 by Androgen Receptor Inhibition in Human Breast Cancer Cells.
P2860
Q27021371-92D87AD4-01AB-4D91-9AFB-6151B191756CQ28479062-E1399783-8918-4DF2-9452-311EBE2080CDQ28743074-C0B9CEE8-545D-49B2-994A-010EA7557695Q33672445-0717FCBC-4013-41C0-B110-3F56E88E2458Q35183172-34F5B22C-8ED5-41A0-9BA6-29FC8AF150CEQ36098645-1FBC2724-FA78-4A13-86B5-9EB2179040B4Q36963697-9D70763F-D43F-41DE-88C1-6D97F51A7E0CQ37031766-1F7407CD-1CDD-4893-BFE4-257FCB704FFCQ37082089-C52E0DBD-14F1-4F1F-B7B9-C99395D9325DQ37702781-72C0FBB4-D531-4D22-9D9D-498B3A1E921EQ38365327-CB1B0D4E-9723-408D-B53C-3D72C605C055Q38615085-17AB8015-8A85-428F-8B21-11DB42337186Q38908290-BA1075CF-1C06-4E54-8878-B9DCB96D22B1Q39316852-53CD1D87-DE27-4DC7-8401-4C820C3D1F36Q42321600-DB2154FA-5F16-44D0-B099-101DF046A604Q46063833-12F0738F-311D-4825-94A6-FBA5DEE26D31Q52715350-83B44FB8-7754-4DC8-99D4-DC2727A0E643
P2860
Androgen receptor-mTOR crosstalk is regulated by testosterone availability: implication for prostate cancer cell survival.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Androgen receptor-mTOR crossta ...... prostate cancer cell survival.
@ast
Androgen receptor-mTOR crossta ...... prostate cancer cell survival.
@en
type
label
Androgen receptor-mTOR crossta ...... prostate cancer cell survival.
@ast
Androgen receptor-mTOR crossta ...... prostate cancer cell survival.
@en
prefLabel
Androgen receptor-mTOR crossta ...... prostate cancer cell survival.
@ast
Androgen receptor-mTOR crossta ...... prostate cancer cell survival.
@en
P2093
P2860
P1433
P1476
Androgen receptor-mTOR crossta ...... prostate cancer cell survival.
@en
P2093
Clement Ip
Haitao Zhang
James L Mohler
Jinrong Cheng
Rishi Raj Chhipa
P2860
P304
P407
P577
2010-10-01T00:00:00Z